Nestlé Launches Major Strategic Overhaul
Nestlé is launching a "performance-driven" transformation of its massive product portfolio. The world's largest food company plans to divest non-core assets and double down on high-margin health and wellness categories, signaling a major shift for the consumer goods giant.
This strategic pivot is driven by CEO Mark Schneider, who since his appointment in 2017 has overseen more than 75 transactions to reshape Nestlé's portfolio. These deals, representing about 18% of the company's portfolio, are designed to focus on high-growth categories like coffee, pet care, and nutritional health. The overhaul involves a significant push into premium products, which now account for 35% of sales, a substantial increase from 11% in 2012. This "premiumization" strategy is evident in acquisitions like Blue Bottle Coffee and the Starbucks retail brand rights, alongside divestments of mainstream North American water brands and the U.S. confections business. A key focus of the new strategy is Nestlé Health Science, which is being built out through acquisitions like Aimmune Therapeutics and Vital Proteins. This division will concentrate on two main pillars: Consumer Care and Medical Nutrition, aiming for leadership in both sectors. CEO Mark Schneider's background of nearly 20 years in the healthcare industry is a notable influence on this strategic direction. The company is also reorganizing its global structure to increase agility. As of early 2025, operations have been streamlined by merging North and Latin America into a single "Zone Americas" and integrating the Greater China region into "Zone Asia, Oceania and Africa". This restructuring is intended to empower local markets and speed up decision-making. To fuel this transformation, Nestlé is targeting significant cost savings, aiming for CHF 2.5 billion by 2027 through a program dubbed "Fuel for Growth". These savings are intended to fund increased investment in marketing and advertising, with a goal of dedicating 9% of sales to these areas by the end of 2025. The new strategy also introduces a performance-linked compensation model for executives, more closely tying pay to metrics like organic sales growth, operating margin improvement, and capital efficiency. This change is meant to instill a stronger performance culture and ensure leadership decisions align directly with shareholder returns.
